Julie O'Neill, EVP Global Operations at ALEXION PHARMACEUTICALS INC (ALXN), sold 4,375 shares at $142.00 ($636K) on 2017-08-31, disclosed to the SEC on 2017-09-05.
Scheduled sale ($636k) by EVP Global Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $142.00 | 612 | $87K | 13.7% |
| 2 | $145.64 | 600 | $87K | 13.7% |
| 3 | $145.81 | 650 | $95K | 14.9% |
| 4 | $145.81 | 1,841 | $268K | 42.2% |
| 5 | $147.00 | 672 | $99K | 15.5% |
| Total | $145.44 avg | 4,375 |
| $636K |
| 100% |
| Filing → |
| ALXN | SELL | 2018-02-08 | $557K | — | Filing → |
| ALXN | SELL | 2018-02-07 | $248K | — | Filing → |
| ALXN | SELL | 2017-08-30 | $1.6M | — | Filing → |